Pharmacy Look-Alike Sound-Alike Medication Audit

Inspection template for auditing look-alike/sound-alike medication controls, including Tall Man lettering, physical separation, labeling, and storage safeguards.

Audit Scope and Documentation

• Current LASA medication list is available and reviewed
  A current, site-specific list of look-alike/sound-alike medication pairs is available for the audit and reflects recent formulary or stocking changes.
• High-risk or frequently confused medications are identified
  Medications with similar names, packaging, strengths, or dosage forms are identified and prioritized for control review.
• Audit references current SOPs and storage standards
  The audit references current pharmacy SOPs, labeling standards, and relevant storage/fire-life-safety requirements applicable to the area inspected.
• Recent incidents, near-misses, or trend data reviewed
  Recent LASA-related incidents, near-misses, or quality trend data were reviewed to focus the inspection on known risk points.
• Inspection area and date documented
  The specific pharmacy area, storage location, and inspection date are documented for traceability.

Tall Man Lettering and Label Clarity

• Tall Man lettering used consistently on LASA labels
  Tall Man lettering is applied consistently to medication labels, shelf labels, bin labels, and other visual controls for identified LASA pairs.
• Label text is legible at point of selection
  Medication names, strengths, and auxiliary warnings are legible at the point where staff select the product.
• Strength and dosage form are clearly differentiated
  Labels clearly distinguish strength and dosage form for products with similar names or packaging.
• Auxiliary warnings or caution labels present where needed
  Auxiliary warnings are used when they reduce selection risk, such as warnings for different concentrations, routes, or formulations.
• Labeling does not obscure critical information
  Tall Man lettering, warning labels, and barcodes do not obscure the drug name, strength, expiration date, or other critical information.

Physical Separation and Storage Controls

• Confusable medications are physically separated
  Look-alike/sound-alike medications are stored in separate bins, shelves, drawers, or locations to reduce the chance of selection error.
• High-alert LASA medications are segregated from routine stock
  High-alert or frequently confused medications are segregated from routine stock and not stored adjacent to similarly named products.
• Shelf/bin organization prevents adjacent placement of similar names
  Adjacent storage does not place similar names, packaging, or strengths side by side without a physical or visual barrier.
• Storage bins are labeled with clear location identifiers
  Bins, shelves, and drawers are labeled so staff can quickly verify the correct product location before selection.
• Expired, quarantined, or returned stock is segregated
  Expired, quarantined, or returned medications are stored separately from active stock and are clearly identified to prevent inadvertent use.

Dispensing and Workflow Safeguards

• Independent double-check required for selected LASA items
  A second-person verification or independent double-check is required for designated LASA or high-risk medications where applicable.
• Barcode or electronic verification used when available
  Barcode scanning or electronic verification is used to confirm product identity when available in the workflow.
• Look-alike products are not repackaged without added safeguards
  If repackaging occurs, the process includes controls that preserve clear identification and prevent confusion with similar products.
• Picking area minimizes distractions and interruptions
  The medication selection area is organized to minimize interruptions, clutter, and distractions that could contribute to selection errors.
• Separate storage used for look-alike oral liquids or injectables
  Similar oral liquids, injectables, or concentrated formulations are stored with additional safeguards when the risk of mix-up is elevated.

Staff Awareness and Corrective Actions

• Staff can describe LASA controls in the area
  Staff interviewed can describe the local controls used to prevent look-alike/sound-alike selection errors.
• Deficiencies documented with corrective action owner and due date
  Any deficiency or non-conformance is documented with a responsible owner and target completion date.
• Repeat issues escalated through quality or safety process
  Repeat LASA issues are escalated through the pharmacy quality, safety, or management review process for trend analysis and prevention.
• Inspector signature
  Inspector signs to confirm the audit findings and any documented deficiencies.